A Randomized, Prospective, Split-Face Pilot Study to Evaluate the Safety and Efficacy of 532-nm and 1,064-nm Picosecond-Domain Neodymium:Yttrium-Aluminum-Garnet Lasers Using a Diffractive Optical Element for Non-Ablative Skin Rejuvenation: Clinical and Histological Evaluation.

ABSTRACT

BACKGROUND: The advent of fractionated picosecond (ps) lasers has provided an opportunity to explore new ways of creating microinjuries in the skin to induce skin rejuvenation. OBJECTIVE: To compare the efficacy and safety of diffractive optical element (DOE)-assisted ps neodymium yttrium-aluminum-garnet (NdYAG) lasers with 532-nm and 1,064-nm wavelengths (532-nm and 1,064-nm NdYAG P-DOE) using a novel fractional handpiece for the treatment of photoaged skin. METHODS: An ex vivo guinea pig skin experiment was performed by evaluating the histology of the skin after 532-nm NdYAG P-DOE irradiation. A randomized, prospective, split-face study was performed on eight subjects with 532-nm and 1,064-nm NdYAG P-DOE. RESULTS: Based on the histological evaluation using ex vivo guinea pig skin, a reasonable safety profile and the potential to generate effective skin rejuvenation was observed using the 532-nm NdYAG P-DOE. Results demonstrated that both 532- and 1,064-nm NdYAG P-DOE were similarly effective in improving skin texture and skin pores; however, 532-nm NdYAG P-DOE was more effective in treating dyspigmentation. CONCLUSION: At a preliminary level, this study revealed that 532-nm and 1,064-nm ps NdYAG lasers using DOE fractional technology may improve photoaged skin. In conclusion, 532-nm NdYAG P-DOE may be especially beneficial for skin with epidermal pigmentary lesions.